Table 1

Definitions for PIP criteria to be modelled as part of the second objective, along with their frequency and cost classification

PIPDefinitionPIP frequencyCosts
START A6ACE inhibitor with systolic heart failure and/or documented coronary artery disease.HighMid
STOPP K2Neuroleptic drugs.MidMid
STOPP D8Anticholinergics/antimuscarinics in patients with delirium or dementia (risk of exacerbation of cognitive impairment).LowHigh
STOPP J6Androgens (male sex hormones) in the absence of primary or secondary hypogonadism (risk of androgen toxicity; no proven benefit outside of the hypogonadism indication).LowLow
  • PIP, potentially inappropriate prescription; STOPP, Screening Tool of Older Persons’ Prescriptions; START, Screening Tool to Alert doctors to Right Treatment.